Hearing loss

Global Disabled and Elderly Assistive Technology Research Report 2024-2030: Growing Emphasis on Workplace Inclusion to Drive Adoption

Retrieved on: 
Tuesday, February 20, 2024

DUBLIN, Feb. 20, 2024 /PRNewswire/ -- The "Disabled and Elderly Assistive Technology - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Feb. 20, 2024 /PRNewswire/ -- The "Disabled and Elderly Assistive Technology - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
  • The report focuses on the evolving landscape of assistive technologies, considering the global economic context and competitive dynamics.
  • An introduction to disabled and elderly assistive technology sets the stage, highlighting the persistent gap in access to such technologies despite advancements.
  • With a rise in the geriatric and disabled population, the need for assistive technologies is growing, driving innovation and market activity.

Pennsylvania youth honored as Prudential Emerging Visionaries

Retrieved on: 
Tuesday, February 13, 2024

NEWARK, N.J., Feb. 13, 2024 /PRNewswire/ -- Sebastian Tan, 16, of Sewickley, and Yaduraj Choudhary, 17, of Downingtown, today were each named a 2024 Prudential Emerging Visionary for their inspiring commitment to improving the lives of others.

Key Points: 
  • Prudential Emerging Visionaries recognizes young people ages 14-18 whose fresh perspectives and innovative solutions address pressing financial and societal challenges in their communities.
  • Prudential Emerging Visionaries is sponsored by Prudential in collaboration with Ashoka, a leading organization in the social impact sector, with advisory support provided by the Financial Health Network, an authority on financial health and a longtime partner of The Prudential Foundation.
  • The program is an evolution of Prudential's Spirit of Community Awards, which honored more than 150,000 outstanding youth volunteers over 26 years.
  • To read about all of this year's Prudential Emerging Visionaries, visit prudential.com/emergingvisionaries .

Prudential Financial introduces its next class of Emerging Visionaries

Retrieved on: 
Tuesday, February 13, 2024

NEWARK, N.J., Feb. 13, 2024 /PRNewswire/ -- Twenty-five young leaders from across the U.S. have been honored by Prudential Financial today as the latest class of Prudential Emerging Visionaries.

Key Points: 
  • NEWARK, N.J., Feb. 13, 2024 /PRNewswire/ -- Twenty-five young leaders from across the U.S. have been honored by Prudential Financial today as the latest class of Prudential Emerging Visionaries.
  • Prudential Emerging Visionaries honors exceptional students ages 14-18 who have created innovative, bold solutions to financial and societal challenges in their communities.
  • Prudential Emerging Visionaries is sponsored by Prudential in collaboration with Ashoka, a leading organization in the social impact sector, with advisory support provided by the Financial Health Network, an authority on financial health and a longtime partner of The Prudential Foundation.
  • For more information about Prudential Emerging Visionaries and to learn more about their stories, visit prudential.com/emergingvisionaries .

Biogen Received European Commission Approval for SKYCLARYS® (omaveloxolone), the First Therapy to Treat Friedreich’s Ataxia

Retrieved on: 
Monday, February 12, 2024

“Friedreich’s ataxia patients treated with SKYCLARYS in the clinical trial experienced important and clinically meaningful improvements for their daily lives.

Key Points: 
  • “Friedreich’s ataxia patients treated with SKYCLARYS in the clinical trial experienced important and clinically meaningful improvements for their daily lives.
  • At the end of the 48-week study, patients who received SKYCLARYS had significantly improved modified Friedreich Ataxia Rating Scale (mFARS) scores relative to placebo.
  • Biogen is committed to working closely with all stakeholders to ensure that eligible European patients can have access to this treatment.
  • SKYCLARYS is also approved for use in the United States, and Biogen is engaging with regulatory authorities in other regions.

One Big Step for Bioelectronic Implant Developers Including US Nuclear’s Partner Grapheton

Retrieved on: 
Monday, February 12, 2024

Current materials used for implants are typically metals and/or polymers which the body rejects as unnatural and foreign.

Key Points: 
  • Current materials used for implants are typically metals and/or polymers which the body rejects as unnatural and foreign.
  • These materials aren’t able to withstand the body’s harsh environment and will degrade and even corrode over time.
  • These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.
  • Investors may find additional information regarding US Nuclear Corp. at the SEC website at http://www.sec.gov , or the company’s website at www.usnuclearcorp.com .

Juntendo University Broadens the Scope of Mitochondrial Disease Testing

Retrieved on: 
Monday, February 12, 2024

TOKYO, Feb. 12, 2024 /PRNewswire/ -- Mitochondrial disease occurs when malfunctioning mitochondria cannot sustain the production of adenosine triphosphate (ATP)—the energy currency of life—in the inner mitochondrial membrane. The loss of this vital molecule has far-reaching consequences that affect various organ systems and can cause psychiatric symptoms, cardiomyopathy, seizures, kidney and liver dysfunction, and hearing loss.

Key Points: 
  • The Intractable Disease Research Center at Juntendo University will conduct broader analyses of mitochondrial genetic data to confirm genetic diagnosis.
  • Unfortunately, mitochondrial disease is the most common congenital metabolic condition, with one case detected for every 5000 live births.
  • In terms of testing, Juntendo University screens many babies diagnosed with mitochondrial disease each year.
  • In this regard, Prof. Murayama's team commenced mitochondrial disease outpatient care at Juntendo Medical Center's Pediatric and Adolescent Department in July 2023.

Cord Blood Registry® (CBR®) by CooperSurgical® and Fulgent Genetics Launch Innovative Genetic Testing

Retrieved on: 
Friday, February 9, 2024

‍TRUMBULL, Conn. and EL MONTE, Calif., Feb. 9, 2024 /PRNewswire/ -- CooperSurgical®, a global leader in fertility and women's health, and Fulgent Genetics, Inc. (NASDAQ: FLGT), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today announced that they have partnered to offer families of Cord Blood Registry® (CBR®) exclusive newborn genetic screening panels.

Key Points: 
  • CBR Portrait includes more than twice as many genes as CBR Snapshot and may identify more rare causes of these conditions.
  • CBR Landscape also includes a pharmacogenetic (PGx) component, which is a type of genetic testing that can determine how a person breaks down or metabolizes certain medications.
  • "Part of our mission is to use our resources and testing to improve the lives of those around us.
  • Newborn genetic analysis serves as an illustration of this commitment, as early intervention may significantly improve health outcomes for many of these conditions."

Organizations Unite to Improve Brain Health

Retrieved on: 
Thursday, February 8, 2024

This initiative brings together leaders from some of the biggest organizations in America to create environments that promote brain health for employees, communities, and consumers as brain health conditions rise, including Alzheimer’s and dementia.

Key Points: 
  • This initiative brings together leaders from some of the biggest organizations in America to create environments that promote brain health for employees, communities, and consumers as brain health conditions rise, including Alzheimer’s and dementia.
  • Among other action items, the Collaborative is working with HERO Health and Mercer to develop a Brain Health Best Practices Scorecard.
  • “We are excited to be working alongside so many innovative organizations in the Collaborative to advance practices and programs in the workplace and throughout communities at large to help optimize brain health,” said Sarah Lenz Lock, Senior Vice President for Policy and Brain Health and Executive Director of the Global Council on Brain Health.
  • For more information about the Business Collaborative for Brain Health and the Brain Health Best Practices Scorecard, click here .

Newly Introduced Bipartisan Bill Seeks to Clarify Fully Implanted Active Middle Ear Hearing Devices as Prosthetics, Not Hearing Aids, Making Them Eligible for Medicare Coverage

Retrieved on: 
Wednesday, February 7, 2024

WHITE BEAR LAKE, Minnesota, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (NASDAQ: “COCH”), a revolutionary hearing health company focused on fully implanted hearing systems, today announced the introduction of a new bipartisan Congressional bill, titled the Hearing Device Coverage Clarification Act. The bill seeks to clarify that fully implanted active middle ear hearing devices are prosthetics and not subject to the current Medicare hearing aid coverage exclusion.

Key Points: 
  • The bill seeks to clarify that fully implanted active middle ear hearing devices are prosthetics and not subject to the current Medicare hearing aid coverage exclusion.
  • The Center for Medicare and Medicaid Services (“CMS”) has broadly interpreted what a “hearing aid” is to include devices that are not hearing aids.
  • Fully Implanted Active Middle Ear Hearing Devices are not hearing aids for a variety of reasons.
  • Envoy Medical is just one of many companies that would begin to reinvest into the fully implanted active middle ear hearing device segment,” Lucas added.

Beltone Serene Hearing Aid Technology Available in Full Range of Popular Styles to Suit All Hearing Needs

Retrieved on: 
Tuesday, February 6, 2024

CHICAGO, Feb. 6, 2024 /PRNewswire/ -- Beltone, named one of America's Best Retailers and Customer Service for Hearing Care by Newsweek, announced today that its innovative Beltone Serene™ hearing aid technology will be available in a full range of popular styles to meet the diverse needs of individuals with hearing loss. Beltone Serene hearing aids, Beltone's smallest devices yet, come highly recommended for hearing in noisy situations,1 and are packed with all the features users need to hear their best in any situation, while embracing the next generation of Bluetooth® connectivity.

Key Points: 
  • David Molella, President of Beltone North America, shares his enthusiasm, "We are thrilled to be pioneers in offering Auracast technology with our Beltone Serene hearing aids as it will significantly improve accessibility in public spaces for individuals with hearing loss.
  • The expanded product line also offers individuals a wider range of options to best suit their needs and preferences, complementing Beltone Serene's cutting-edge next generation of hearing and connectivity."
  • 2
    Plus, all Beltone Serene styles are discreetly designed for all-day comfort, weatherproof, sweatproof, and available in a diverse range of color options to match individuals' unique styles.
  • The Beltone Serene extended family of hearing aids will be available at Beltone locations nationwide starting February 22, 2024.